EUDA Health reports weak half-year results: what it means for EUDA Health stock

Published on 10/05/2026 at 00:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Six-month revenue rose to USD 3.47 million, up 13.43 percent year over year. For EUDA Health stock, cash was USD 365,904 at June 30, 2026.

EUDA, VGG3142E1473, Illustration mit AI erstellt.

EUDA Health (ISIN VGG3142E1473) reported six-month revenue of USD 3.47 million for the period ended June 30, 2026, up 13.43 percent from USD 3.06 million a year earlier. The results also disclosed a substantial going-concern risk, giving the figures a sharper meaning for EUDA Health stock.

Revenue improves while losses narrow

According to StockTitan on September 29, 2026, EUDA's net loss for the six months ended June 30, 2026 narrowed to USD 796,950 from USD 1,201,696 in the comparable 2025 period. That is a 33.68 percent reduction in the loss, while the company generated USD 1.28 million in gross profit during the same six-month period.

The revenue mix remained concentrated in two operations. Property management services contributed USD 2.26 million, while holistic wellness consumer products and services generated USD 1.21 million in the first half of 2026, according to the filing summarized by StockTitan.

Quarterly figures missed expectations

MarketBeat reported on September 29, 2026, that second-quarter revenue was USD 1.73 million against a USD 9.61 million consensus estimate. Diluted earnings per share were negative USD 0.17 versus expected earnings per share of USD 0.40, a shortfall of USD 0.57.

The balance sheet explains why the revenue comparison is only one part of the story. Cash and cash equivalents were USD 365,904 at June 30, 2026, while net cash used in operating activities reached USD 1.21 million for the six-month period, according to StockTitan. Management said recurring losses and negative operating cash flows create substantial doubt about the company's ability to continue as a going concern within one year after issuance of the statements.

Nasdaq valuation remains wide

EUDA was last quoted at USD 17.24 on Nasdaq on October 2, 2026 at 4:00 p.m. ET. Its market capitalization was USD 32.2 million, and the 52-week range was USD 5.26 to USD 86.00, putting the latest Nasdaq quote 79.95 percent below the yearly high.

The share count also changed materially during the reporting period. EUDA reported 2,994,325 ordinary shares outstanding at June 30, 2026, compared with 1,857,653 at December 31, 2025, an increase of 61.18 percent. For investors, the combination of revenue growth, a smaller reported loss and continued funding pressure is the central tension in the latest filing.